AAAAAA

   
Results: 1-9 |
Results: 9
PERSISTENT ACTIVATION OF THE DOPAMINE D-1 RECEPTOR CONTRIBUTES TO PROLONGED RECEPTOR DESENSITIZATION - STUDIES WITH A-77636
Authors: LIN CW BIANCHI BR MILLER TR STASHKO MA WANG SS CURZON P BEDNARZ L ASIN KE BRITTON DR
Citation: Cw. Lin et al., PERSISTENT ACTIVATION OF THE DOPAMINE D-1 RECEPTOR CONTRIBUTES TO PROLONGED RECEPTOR DESENSITIZATION - STUDIES WITH A-77636, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1022-1029
HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431
Authors: SHIOSAKI K ASIN KE BRITTON DR GIARDINA WJ BEDNARZ L MAHAN L MIKUSA J NIKKEL A WISMER C
Citation: K. Shiosaki et al., HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431, European journal of pharmacology, 317(2-3), 1996, pp. 183-190
MK-801 DIFFERENTIALLY AFFECTS DOPAMINE D1 AND D2 RECEPTOR AGONIST-INDUCED BEHAVIORAL TOLERANCE AND DESENSITIZATION
Authors: ASIN KE BEDNARZ L NIKKEL AL
Citation: Ke. Asin et al., MK-801 DIFFERENTIALLY AFFECTS DOPAMINE D1 AND D2 RECEPTOR AGONIST-INDUCED BEHAVIORAL TOLERANCE AND DESENSITIZATION, Brain research, 725(1), 1996, pp. 67-74
A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE
Authors: ASIN KE NIKKEL A BEDNARZ L DOMINO EF SHIOSAKI K
Citation: Ke. Asin et al., A-86929 - A SELECTIVE DOPAMINE D1 RECEPTOR AGONIST EFFICACIOUS IN RODENT AND PRIMATE MODELS OF PARKINSONS-DISEASE, The FASEB journal, 9(3), 1995, pp. 395-395
ROTATION AND STRIATAL C-FOS EXPRESSION AFTER REPEATED, DAILY TREATMENT WITH SELECTIVE DOPAMINE-RECEPTOR AGONISTS AND LEVODOPA
Authors: ASIN KE BEDNARZ L NIKKEL A PERNER R
Citation: Ke. Asin et al., ROTATION AND STRIATAL C-FOS EXPRESSION AFTER REPEATED, DAILY TREATMENT WITH SELECTIVE DOPAMINE-RECEPTOR AGONISTS AND LEVODOPA, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1483-1490
TETRAPEPTIDE CCK-A AGONISTS - EFFECT OF BACKBONE N-METHYLATIONS ON IN-VITRO AND IN-VIVO CCK ACTIVITY
Authors: HOLLADAY MW KOPECKA H MILLER TR BEDNARZ L NIKKEL AL BIANCHI BR WITTE DG SHIOSAKI K LIN CW ASIN KE NADZAN AM
Citation: Mw. Holladay et al., TETRAPEPTIDE CCK-A AGONISTS - EFFECT OF BACKBONE N-METHYLATIONS ON IN-VITRO AND IN-VIVO CCK ACTIVITY, Journal of medicinal chemistry, 37(5), 1994, pp. 630-635
TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS
Authors: ELLIOTT RL KOPECKA H BENNETT MJ SHUE YK CRAIG R LIN CW BIANCHI BR MILLER TR WITTE DG STASHKO MA ASIN KE NIKKEL A BEDNARZ L NADZAN AM
Citation: Rl. Elliott et al., TETRAPEPTIDE CCK AGONISTS - STRUCTURE-ACTIVITY STUDIES ON MODIFICATIONS AT THE N-TERMINUS, Journal of medicinal chemistry, 37(2), 1994, pp. 309-313
NOVEL ASP(32)-REPLACEMENT TETRAPEPTIDE ANALOGS AS POTENT AND SELECTIVE CCK-A AGONISTS
Authors: ELLIOTT RL KOPECKA H TUFANO MD SHUE YK GAURI AJ LIN CW BIANCHI BR MILLER TR WITTE DG STASHKO MA ASIN KE NIKKEL AL BEDNARZ L NADZAN AM
Citation: Rl. Elliott et al., NOVEL ASP(32)-REPLACEMENT TETRAPEPTIDE ANALOGS AS POTENT AND SELECTIVE CCK-A AGONISTS, Journal of medicinal chemistry, 37(11), 1994, pp. 1562-1568
CCK-A-SELECTIVE TETRAPEPTIDES CONTAINING LYS(N-E)-AMIDE RESIDUES - FAVORABLE IN-VIVO AND IN-VITRO EFFECTS OF N-METHYLATION AT THE ASPARTYL RESIDUE
Authors: BENNETT MJ NIKKEL AL BIANCHI BR MILLER TR BEDNARZ L WITTE DG STASHKO M WANG SS GORE PA ASIN KE LIN CW NADZAN AM HOLLADAY MW
Citation: Mj. Bennett et al., CCK-A-SELECTIVE TETRAPEPTIDES CONTAINING LYS(N-E)-AMIDE RESIDUES - FAVORABLE IN-VIVO AND IN-VITRO EFFECTS OF N-METHYLATION AT THE ASPARTYL RESIDUE, Journal of medicinal chemistry, 37(11), 1994, pp. 1569-1571
Risultati: 1-9 |